跳至主要内容
临床试验/NCT02987491
NCT02987491已完成不适用

Exercise and Insulin Signaling in Human Skeletal Muscle

Oregon State University2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2016年11月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
2
主要终点
Skeletal muscle insulin sensitivity

研究概览

简要总结

Obesity is associated with a decrease in skeletal muscle insulin sensitivity. Aerobic exercise can increase insulin sensitivity in the few hours following exercise, however the cellular mechanisms are not completely understood. The current project is to investigate mechanisms of exercise improvements to skeletal muscle insulin sensitivity.

详细描述

Study Overview: We are investigating the mechanisms by which exercise improves the response of skeletal muscle to insulin in lean and obese adults. Participants will complete 4 study visits consisting of: 1) screening visit, 2) maximal exercise test visit, and then a randomized order of 3) a resting metabolic study visit, and 4) an exercise metabolic study visit. Metabolic study visits for resting and exercise conditions will be identical, other than remaining sedentary or performing exercise. Skeletal muscle biopsy samples will be collected during resting, immediately post-exercise and during insulin stimulated conditions.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Males or Females
  • Aged 18-45 years
  • Normal weight (body mass index [BMI] 18-26 kg/m2) or obese (BMI 30-46 kg/m2)
  • Sedentary (< 1 hour of planned physical activity per week for ≥ 6 months)
  • Weight stable (< 2 kg change in body mass for ≥ 6 months)
  • Non-smokers (no tobacco or nicotine use for ≥ 1 year)

排除标准

  • Hypertension (systolic blood pressure >140 mmHg, diastolic blood pressure > 90mmHg)
  • Chronic health condition including diabetes, cardiovascular disease, treated hypertension, cancer, anemia, uncontrolled hyper- or hypothyroidism.
  • Pregnant, nursing, irregular menses or post-menopausal (if female)
  • Hyperglycemia (fasting glucose >126 mg/dl)
  • Hypercholesterolemia (fasting LDL>140mg/dl)
  • Hemoglobin < 13.0 g/dl (males), < 11.5 g/dl (females)
  • Compromised renal function (outside 135-145 mmol/L sodium, 3.5-5.1 mmol/L potassium)
  • Lidocaine allergy
  • Medications including β-blockers, angiotensin converting enzyme inhibitors, insulin, thiazolidinediones, metformin, sulfonylureas, chronic non-steroidal anti-inflammatory use, anti-coagulant (e.g. warfarin), current antibiotics, opiates, monoamine oxidase inhibitors, benzodiazepines, or others that may impact the study outcomes
  • Any physical limitation that prevents a participant from safely completing the exercise test
  • Due to the risks associated with the current protocol, individuals with a diminished capacity to consent will be excluded. Similarly, due to the need for constant, accurate participant monitoring during metabolic study activities, participants will need to clearly understand verbal and written English. Participants who cannot clearly understand verbal and written English will be excluded.

结局指标

主要结局

Skeletal muscle insulin sensitivity

时间窗: 2 hours following rest or exercise

Skeletal muscle insulin sensitivity will be measured by hyperinsulinemic-euglycemic clamp.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验